{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T19:37:53Z","timestamp":1783453073332,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangxi Medical High-level Backbone Talents \u201c139\u201d Program","award":["No. G20190100"],"award-info":[{"award-number":["No. G20190100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Levosimendan exerts positive inotropic and vasodilatory effects. Currently, its effects on right heart function remain uncertain. This systematic review and meta-analysis is intended to illustrate the impacts of levosimendan on systolic function of the right heart in patients with heart dysfunction. We systematically searched electronic databases (PubMed, the Cochrane Library, Embase and Web of Science) up to November 30, 2020, and filtered eligible studies that reported the impacts of levosimendan on right heart function. Of these, only studies whose patients suffered from heart dysfunction or pulmonary hypertension were included. Additionally, patients were divided into two groups (given levosimendan or not) in the initial research. Then, RevMan5.3 was used to conduct further analysis. A total of 8 studies comprising 390 patients were included. The results showed that after 24\u00a0h of levosimendan, patients\u2019 right ventricular fractional area change [3.17, 95% CI (2.03, 4.32), P\u2009&lt;\u20090.00001], tricuspid annular plane systolic excursion [1.26, 95% CI (0.35, 2.16), P\u2009=\u20090.007] and tricuspid annular peak systolic velocity [0.86, 95% CI (0.41, 1.32), P\u2009=\u20090.0002] were significantly increased compared to the control group. And there is an increasing trend of cardiac output in levosimendan group [1.06, 95% CI (\u2212\u00a00.16, 2.29), P\u2009=\u20090.09 ] .Furthermore, patients\u2019 systolic pulmonary arterial pressure [\u2212\u00a05.57, 95% CI (\u2212\u00a07.60, \u2212\u00a03.54), P\u2009&lt;\u20090.00001] and mean pulmonary arterial pressure [\u2212\u00a01.01, 95% CI (\u2212\u00a01.64, \u2212\u00a00.37), P\u2009=\u20090.002] were both significantly decreased, whereas changes in pulmonary vascular resistance [\u2212\u00a055.88, 95% CI (\u2212\u00a0206.57, 94.82), P\u2009=\u20090.47] were not significant. Our study shows that in patients with heart dysfunction, levosimendan improves systolic function of the right heart and decreases the pressure of the pulmonary artery.<\/jats:p>","DOI":"10.1038\/s41598-021-03317-5","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T11:07:13Z","timestamp":1639652833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The effect of levosimendan on right ventricular function in patients with heart dysfunction: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"11","author":[{"given":"Yaoshi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanghong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"3317_CR1","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.2174\/1381612820666140325121452","volume":"20","author":"JL Orriach Guerrero","year":"2014","unstructured":"Orriach Guerrero, J. L. et al. Preoperative levosimendan: A new way for organoprotection. Curr. Pharm. Des. 20, 5476\u20135483 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"3317_CR2","first-page":"127","volume":"33","author":"HY Chang","year":"2017","unstructured":"Chang, H. Y. et al. One-year outcomes of acute decompensated systolic heart failure in Taiwan: Lessons from TSOC-HFrEF registry. Acta Cardiol. Sin. 33, 127\u2013138 (2017).","journal-title":"Acta Cardiol. Sin."},{"key":"3317_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","volume":"37","author":"S Ghio","year":"2001","unstructured":"Ghio, S. et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J. Am. Coll. Cardiol. 37, 183\u2013188 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"3317_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0828-282X(08)70687-1","volume":"24","author":"S Turkoglu","year":"2008","unstructured":"Turkoglu, S., Erden, M. & Ozdemir, M. Isolated right ventricular infarction due to occlusion of the right ventricular branch in the absence of percutaneous coronary intervention. Can. J. Cardiol. 24, 793\u2013794 (2008).","journal-title":"Can. J. Cardiol."},{"key":"3317_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/CIRCRESAHA.117.309345","volume":"121","author":"D Corrado","year":"2017","unstructured":"Corrado, D., Basso, C. & Judge, D. P. Arrhythmogenic cardiomyopathy. Circ. Res. 121, 784\u2013802 (2017).","journal-title":"Circ. Res."},{"key":"3317_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11897-018-0389-5","volume":"15","author":"W Lin","year":"2018","unstructured":"Lin, W., Poh, A. L. & Tang, W. H. W. Novel insights and treatment strategies for right heart failure. Curr. Heart Fail. Rep. 15, 141\u2013155 (2018).","journal-title":"Curr. Heart Fail. Rep."},{"key":"3317_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1161\/CIRCHEARTFAILURE.109.900134","volume":"3","author":"D Verhaert","year":"2010","unstructured":"Verhaert, D. et al. Right ventricular response to intensive medical therapy in advanced decompensated heart failure. Circ. Heart Fail. 3, 340\u2013346 (2010).","journal-title":"Circ. Heart Fail."},{"key":"3317_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","volume":"122","author":"M Humbert","year":"2010","unstructured":"Humbert, M. et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122, 156\u2013163 (2010).","journal-title":"Circulation"},{"key":"3317_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","volume":"159","author":"Z Papp","year":"2012","unstructured":"Papp, Z. et al. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. Int. J. Cardiol. 159, 82\u201387 (2012).","journal-title":"Int. J. Cardiol."},{"key":"3317_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ijcard.2015.10.240","volume":"203","author":"P Pollesello","year":"2016","unstructured":"Pollesello, P., Papp, Z. & Papp, J. G. Calcium sensitizers: What have we learned over the last 25 years?. Int. J. Cardiol. 203, 543\u2013548 (2016).","journal-title":"Int. J. Cardiol."},{"key":"3317_CR11","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1016\/S0828-282X(09)70721-4","volume":"25","author":"D Duman","year":"2009","unstructured":"Duman, D., Palit, F., Simsek, E., Bilgehan, K. & Sacide, A. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure. Can. J. Cardiol. 25, e353\u2013e356 (2009).","journal-title":"Can. J. Cardiol."},{"key":"3317_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5603\/CJ.a2014.0044","volume":"22","author":"E Oner","year":"2015","unstructured":"Oner, E. et al. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure. Cardiol. J. 22, 87\u201393 (2015).","journal-title":"Cardiol. J."},{"key":"3317_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5830\/CVJA-2020-008","volume":"31","author":"XR Cui","year":"2020","unstructured":"Cui, X. R. et al. Short-term efficacy and safety of levosimendan in patients with chronic systolic heart failure. Cardiovasc. J. Afr. 31, 196\u2013200 (2020).","journal-title":"Cardiovasc. J. Afr."},{"key":"3317_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","volume":"352","author":"D Moher","year":"1998","unstructured":"Moher, D. et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 352, 609\u2013613 (1998).","journal-title":"Lancet"},{"key":"3317_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557\u2013560 (2003).","journal-title":"BMJ"},{"key":"3317_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/0091270008325150","volume":"49","author":"FX Kleber","year":"2009","unstructured":"Kleber, F. X. et al. Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: Results of a pilot study. J. Clin. Pharmacol. 49, 109\u2013115 (2009).","journal-title":"J. Clin. Pharmacol."},{"key":"3317_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5830\/CVJA-2013-047","volume":"24","author":"O Ersoy","year":"2013","unstructured":"Ersoy, O. et al. Effectiveness of prophylactic levosimendan in high-risk valve surgery patients. Cardiovasc. J. Afr. 24, 260\u2013264 (2013).","journal-title":"Cardiovasc. J. Afr."},{"key":"3317_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1742-1241.2007.01510.x","volume":"62","author":"H Duygu","year":"2008","unstructured":"Duygu, H. et al. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure. Int. J. Clin. Pract. 62, 228\u2013233 (2008).","journal-title":"Int. J. Clin. Pract."},{"key":"3317_CR19","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.amjcard.2006.06.052","volume":"98","author":"JT Parissis","year":"2006","unstructured":"Parissis, J. T. et al. Effects of levosimendan on right ventricular function in patients with advanced heart failure. Am. J. Cardiol. 98, 1489\u20131492 (2006).","journal-title":"Am. J. Cardiol."},{"key":"3317_CR20","first-page":"585","volume":"35","author":"YB Wang","year":"2019","unstructured":"Wang, Y. B. et al. Effects of levosimendan on right ventricular function in patients with acute decompensated heart failure. Acta Cardiol. Sin. 35, 585\u2013591 (2019).","journal-title":"Acta Cardiol. Sin."},{"key":"3317_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2459\/JCM.0000000000000537","volume":"18","author":"C Giannini","year":"2017","unstructured":"Giannini, C. et al. Effects of levosimendan in patients with severe functional mitral regurgitation undergoing MitraClip implantation. J. Cardiovasc. Med. (Hagerstown). 18, 679\u2013686 (2017).","journal-title":"J. Cardiovasc. Med. (Hagerstown)."},{"key":"3317_CR22","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.ejheart.2005.05.001","volume":"7","author":"D Moertl","year":"2005","unstructured":"Moertl, D., Berger, R., Huelsmann, M., Bojic, A. & Pacher, R. Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure. Eur. J. Heart Fail. 7, 1156\u20131163 (2005).","journal-title":"Eur. J. Heart Fail."},{"key":"3317_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00380-008-1077-2","volume":"24","author":"MB Yilmaz","year":"2009","unstructured":"Yilmaz, M. B. et al. Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure. Heart Vessels. 24, 16\u201321 (2009).","journal-title":"Heart Vessels."},{"key":"3317_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.lfs.2017.07.001","volume":"184","author":"J Qiu","year":"2017","unstructured":"Qiu, J. et al. Efficacy and safety of levosimendan in patients with acute right heart failure: A meta-analysis. Life Sci. 184, 30\u201336 (2017).","journal-title":"Life Sci."},{"key":"3317_CR25","first-page":"523","volume":"33","author":"O Ozturk","year":"2017","unstructured":"Ozturk, O., Ozturk, U. & Zilkif Karahan, M. Assesment of right ventricle function with speckle tracking echocardiography after the percutaneous closure of atrial septal defect. Acta Cardiol. Sin. 33, 523\u2013529 (2017).","journal-title":"Acta Cardiol. Sin."},{"key":"3317_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski, L. G. et al. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 23, 685\u2013713 (2010).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"3317_CR27","first-page":"461","volume":"135","author":"D T\u00fcller","year":"2005","unstructured":"T\u00fcller, D., Steiner, M., Wahl, A., Kabok, M. & Seiler, C. Systolic right ventricular function assessment by pulsed wave tissue Doppler imaging of the tricuspid annulus. Swiss Med. Wkly. 135, 461\u2013468 (2005).","journal-title":"Swiss Med. Wkly."},{"key":"3317_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1540-8175.2007.00587.x","volume":"25","author":"S De Castro","year":"2008","unstructured":"De Castro, S. et al. Usefulness of tricuspid annular velocity in identifying global RV dysfunction in patients with primary pulmonary hypertension: A comparison with 3D echo-derived right ventricular ejection fraction. Echocardiography 25, 289\u2013293 (2008).","journal-title":"Echocardiography"},{"key":"3317_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jacc.2016.10.047","volume":"69","author":"A Vonk Noordegraaf","year":"2017","unstructured":"Vonk Noordegraaf, A., Westerhof, B. E. & Westerhof, N. The relationship between the right ventricle and its load in pulmonary hypertension. J. Am. Coll. Cardiol. 69, 236\u2013243 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"3317_CR30","first-page":"1055","volume":"466","author":"S Rain","year":"2014","unstructured":"Rain, S. et al. Pressure-overload-induced right heart failure. Pflugers. Arch. 466, 1055\u20131063 (2014).","journal-title":"Pflugers. Arch."},{"key":"3317_CR31","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jacc.2010.05.046","volume":"56","author":"T Lahm","year":"2010","unstructured":"Lahm, T. et al. Medical and surgical treatment of acute right ventricular failure. J. Am. Coll. Cardiol. 56, 1435\u20131446 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"3317_CR32","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1517\/14656566.6.15.2741","volume":"6","author":"JT Parissis","year":"2005","unstructured":"Parissis, J. T. et al. Levosimendan for the treatment of acute heart failure syndromes. Expert. Opin. Pharmacother. 6, 2741\u20132751 (2005).","journal-title":"Expert. Opin. Pharmacother."},{"key":"3317_CR33","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2165\/00003495-200161050-00006","volume":"61","author":"DP Figgitt","year":"2001","unstructured":"Figgitt, D. P., Gillies, P. S. & Goa, K. L. Levosimendan. Drugs 61, 613\u2013627 (2001).","journal-title":"Drugs"},{"key":"3317_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15420\/cfr.2020.03","volume":"6","author":"Z Papp","year":"2020","unstructured":"Papp, Z. et al. Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use. Card. Fail. Rev. 6, 19 (2020).","journal-title":"Card. Fail. Rev."},{"key":"3317_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijcard.2016.07.202","volume":"222","author":"D Farmakis","year":"2016","unstructured":"Farmakis, D. et al. Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper. Int. J. Cardiol. 222, 303\u2013312 (2016).","journal-title":"Int. J. Cardiol."},{"key":"3317_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijcard.2015.08.188","volume":"202","author":"S Silvetti","year":"2016","unstructured":"Silvetti, S. & Nieminen, M. S. Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis. Int. J. Cardiol. 202, 138\u2013143 (2016).","journal-title":"Int. J. Cardiol."},{"key":"3317_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/ehf2.12177","volume":"4","author":"S Silvetti","year":"2017","unstructured":"Silvetti, S., Belletti, A., Fontana, A. & Pollesello, P. Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: A meta-analysis of randomized trials. ESC Heart Fail. 4, 595\u2013604 (2017).","journal-title":"ESC Heart Fail."},{"key":"3317_CR38","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/ejhf.118","volume":"16","author":"J Altenberger","year":"2014","unstructured":"Altenberger, J. et al. Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: A multicentre randomized trial. Eur. J. Heart Fail. 16, 898\u2013906 (2014).","journal-title":"Eur. J. Heart Fail."},{"key":"3317_CR39","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s40256-017-0237-0","volume":"17","author":"G Shang","year":"2017","unstructured":"Shang, G. et al. Effects of levosimendan on patients with heart failure complicating acute coronary syndrome: A meta-analysis of randomized controlled trials. Am. J. Cardiovasc. Drugs. 17, 453\u2013463 (2017).","journal-title":"Am. J. Cardiovasc. Drugs."},{"key":"3317_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/AC.71.4.3159693","volume":"71","author":"AK Mansiroglu","year":"2016","unstructured":"Mansiroglu, A. K. et al. Assessment of sustained effects of levosimendan on right ventricular systolic functions in patients with advanced heart failure. Acta Cardiol. 71, 411\u2013415 (2016).","journal-title":"Acta Cardiol."},{"key":"3317_CR41","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.5603\/KP.2013.0258","volume":"71","author":"F Alibaz-Oner","year":"2013","unstructured":"Alibaz-Oner, F., Gurbuz, O. Z., Oner, E., Yurdakul, S. & Erguney, M. Impact of levosimendan on right ventricular functions by using novel tissue Doppler derived indices in patients with ischaemic left ventricular failure. Kardiol Pol. 71, 1036\u20131041 (2013).","journal-title":"Kardiol Pol."},{"key":"3317_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.amjcard.2005.03.092","volume":"96","author":"JT Parissis","year":"2005","unstructured":"Parissis, J. T. et al. Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure. Am. J. Cardiol. 96, 423\u2013426 (2005).","journal-title":"Am. J. Cardiol."},{"key":"3317_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/bja\/aeq402","volume":"106","author":"H Leppikangas","year":"2011","unstructured":"Leppikangas, H. et al. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery. Br. J. Anaesth. 106, 298\u2013304 (2011).","journal-title":"Br. J. Anaesth."},{"key":"3317_CR44","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1067\/mcp.2000.110972","volume":"68","author":"H Ukkonen","year":"2000","unstructured":"Ukkonen, H. et al. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin. Pharmacol. Ther. 68, 522\u2013531 (2000).","journal-title":"Clin. Pharmacol. Ther."},{"key":"3317_CR45","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1161\/01.CIR.102.18.2222","volume":"102","author":"MT Slawsky","year":"2000","unstructured":"Slawsky, M. T. et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 102, 2222\u20132227 (2000).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03317-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03317-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03317-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T19:11:10Z","timestamp":1676056270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03317-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["3317"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-03317-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]},"assertion":[{"value":"23 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24097"}}